HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.

Abstract
Acute and post-acute neurological symptoms, signs and diagnoses have been documented in an increasing number of patients infected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19). In this review, we aimed to summarize the current literature addressing neurological events following SARS-CoV-2 infection, discuss limitations in the existing literature and suggest future directions that would strengthen our understanding of the neurological sequelae of COVID-19. The presence of neurological manifestations (symptoms, signs or diagnoses) both at the onset or during SARS-CoV-2 infection is associated with a more severe disease, as demonstrated by a longer hospital stay, higher in-hospital death rate or the continued presence of sequelae at discharge. Although biological mechanisms have been postulated for these findings, evidence-based data are still lacking to clearly define the incidence, range of characteristics and outcomes of these manifestations, particularly in non-hospitalized patients. In addition, data from low- and middle-income countries are scarce, leading to uncertainties in the measure of neurological findings of COVID-19, with reference to geography, ethnicity, socio-cultural settings, and health care arrangements. As a consequence, at present a specific phenotype that would specify a post-COVID (or long-COVID) neurological syndrome has not yet been identified.
AuthorsEttore Beghi, Giorgia Giussani, Erica Westenberg, Ricardo Allegri, David Garcia-Azorin, Alla Guekht, Jennifer Frontera, Miia Kivipelto, Francesca Mangialasche, Elizabeta B Mukaetova-Ladinska, Kameshwar Prasad, Neerja Chowdhary, Andrea Sylvia Winkler
JournalJournal of neurology (J Neurol) Vol. 269 Issue 5 Pg. 2265-2274 (May 2022) ISSN: 1432-1459 [Electronic] Germany
PMID34674005 (Publication Type: Journal Article, Review)
Copyright© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Topics
  • COVID-19 (complications)
  • Hospital Mortality
  • Humans
  • Nervous System Diseases (epidemiology, etiology)
  • SARS-CoV-2
  • Post-Acute COVID-19 Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: